Natera, Inc. , a global leader in cell-free DNA (cfDNA) and genetic testing, today announced that the company will present new data on its 385-gene kidney genetic test, Renasighttm, at the annual ...
Arialys Therapeutics, a clinical-stage biotechnology company pioneering new precision medicines for autoimmune neuropsychiatry, today announced the appointment of Sankalp "Sam" Gokhale, M.D., as Chief ...